Tech Company Financing Transactions
Kriya Therapeutics Funding Round
Kriya Therapeutics, based in Redwood City, secured $270 million in investment from Patient Square Capital, Bluebird Ventures and CAM Capital.
Transaction Overview
Company Name
Announced On
5/16/2022
Transaction Type
Venture Equity
Amount
$270,000,000
Round
Series C
Investors
Proceeds Purpose
Proceeds from this financing will support the advancement of Kriya's pipeline and continued scaling of its engineering, manufacturing, and computational platforms.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1100 Island Dr. 203
Redwood City, CA 94065
USA
Redwood City, CA 94065
USA
Phone
Undisclosed
Website
Email Address
Overview
The era of gene therapy has arrived. Our mission at Kriya Therapeutics is to expand the reach of gene therapy to address highly prevalent and serious diseases affecting millions of patients. Kriya is a next-generation gene therapy company focused on designing and developing transformative new treatments for highly prevalent and severe chronic diseases.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 5/16/2022: Gusto Collective venture capital transaction
Next: 5/16/2022: SOLiTHOR venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs